Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 1-Year High – Here’s Why

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)’s stock price reached a new 52-week high during trading on Friday . The company traded as high as $9.84 and last traded at $9.65, with a volume of 32902 shares changing hands. The stock had previously closed at $9.61.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.

Fresenius SE & Co. KGaA Trading Up 0.4 %

The firm’s 50-day moving average price is $8.91 and its 200-day moving average price is $8.96. The company has a current ratio of 1.36, a quick ratio of 1.05 and a debt-to-equity ratio of 0.57.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter. The firm had revenue of $5.90 billion for the quarter. As a group, analysts anticipate that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.